vs
Priority Technology Holdings, Inc.（PRTH）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Priority Technology Holdings, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$247.1M vs $207.3M），Priority Technology Holdings, Inc.净利率更高（3.6% vs -62.0%，领先65.6%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 8.8%），Priority Technology Holdings, Inc.自由现金流更多（$30.9M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 9.6%）
Priority Technology Holdings, Inc.是一家聚焦信息技术领域的企业，业务围绕计算机、通信系统等相关信息设备展开，涵盖信息的创建、处理、存储、检索与传输等相关信息技术应用服务，依托计算机科学与工程技术支撑业务开展。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
PRTH vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $247.1M | $207.3M |
| 净利润 | $8.9M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 13.6% | -54.7% |
| 净利率 | 3.6% | -62.0% |
| 营收同比 | 8.8% | 25.9% |
| 净利润同比 | 23.9% | 3.5% |
| 每股收益（稀释后） | $0.10 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $247.1M | $207.3M | ||
| Q3 25 | $241.4M | $159.9M | ||
| Q2 25 | $239.8M | $166.5M | ||
| Q1 25 | $224.6M | $139.3M | ||
| Q4 24 | $227.1M | $164.6M | ||
| Q3 24 | $227.0M | $139.5M | ||
| Q2 24 | $219.9M | $147.0M | ||
| Q1 24 | $205.7M | $108.8M |
| Q4 25 | $8.9M | $-128.6M | ||
| Q3 25 | $27.6M | $-180.4M | ||
| Q2 25 | $10.9M | $-115.0M | ||
| Q1 25 | $8.3M | $-151.1M | ||
| Q4 24 | $7.2M | $-133.2M | ||
| Q3 24 | $10.6M | $-133.5M | ||
| Q2 24 | $994.0K | $-131.6M | ||
| Q1 24 | $5.2M | $-170.7M |
| Q4 25 | 13.6% | -54.7% | ||
| Q3 25 | 15.6% | -106.9% | ||
| Q2 25 | 15.6% | -64.8% | ||
| Q1 25 | 14.5% | -102.6% | ||
| Q4 24 | 15.0% | -74.3% | ||
| Q3 24 | 16.8% | -94.6% | ||
| Q2 24 | 15.1% | -79.1% | ||
| Q1 24 | 13.6% | -151.9% |
| Q4 25 | 3.6% | -62.0% | ||
| Q3 25 | 11.4% | -112.8% | ||
| Q2 25 | 4.5% | -69.0% | ||
| Q1 25 | 3.7% | -108.5% | ||
| Q4 24 | 3.2% | -80.9% | ||
| Q3 24 | 4.7% | -95.7% | ||
| Q2 24 | 0.5% | -89.5% | ||
| Q1 24 | 2.5% | -156.8% |
| Q4 25 | $0.10 | $-1.28 | ||
| Q3 25 | $0.34 | $-1.81 | ||
| Q2 25 | $0.14 | $-1.17 | ||
| Q1 25 | $0.10 | $-1.57 | ||
| Q4 24 | $-0.05 | $-1.34 | ||
| Q3 24 | $0.07 | $-1.40 | ||
| Q2 24 | $-0.23 | $-1.52 | ||
| Q1 24 | $-0.10 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $77.2M | $421.0M |
| 总债务越低越好 | $1.0B | — |
| 股东权益账面价值 | $-100.4M | $-80.0M |
| 总资产 | $2.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $77.2M | $421.0M | ||
| Q3 25 | $57.0M | $202.5M | ||
| Q2 25 | $50.6M | $176.3M | ||
| Q1 25 | $47.6M | $127.1M | ||
| Q4 24 | $58.6M | $174.0M | ||
| Q3 24 | $41.1M | $150.6M | ||
| Q2 24 | $34.6M | $480.7M | ||
| Q1 24 | $34.3M | $112.3M |
| Q4 25 | $1.0B | — | ||
| Q3 25 | $997.5M | — | ||
| Q2 25 | $917.0M | — | ||
| Q1 25 | $918.9M | — | ||
| Q4 24 | $920.9M | — | ||
| Q3 24 | $808.1M | — | ||
| Q2 24 | $809.0M | — | ||
| Q1 24 | $631.4M | — |
| Q4 25 | $-100.4M | $-80.0M | ||
| Q3 25 | $-110.3M | $9.2M | ||
| Q2 25 | $-146.1M | $151.3M | ||
| Q1 25 | $-158.3M | $144.2M | ||
| Q4 24 | $-166.8M | $255.0M | ||
| Q3 24 | $-165.8M | $346.8M | ||
| Q2 24 | $-172.1M | $432.4M | ||
| Q1 24 | $-159.9M | $140.3M |
| Q4 25 | $2.4B | $1.5B | ||
| Q3 25 | $2.2B | $1.2B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.8B | $1.5B | ||
| Q3 24 | $1.8B | $1.5B | ||
| Q2 24 | $1.7B | $1.6B | ||
| Q1 24 | $1.6B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $30.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | 12.5% | -48.6% |
| 资本支出强度资本支出/营收 | 2.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 4.12× | — |
| 过去12个月自由现金流最近4个季度 | $75.1M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $36.8M | $-99.8M | ||
| Q3 25 | $36.1M | $-91.4M | ||
| Q2 25 | $17.1M | $-108.3M | ||
| Q1 25 | $10.0M | $-166.5M | ||
| Q4 24 | $23.8M | $-79.3M | ||
| Q3 24 | $19.8M | $-67.0M | ||
| Q2 24 | $28.7M | $-77.0M | ||
| Q1 24 | $13.3M | $-190.7M |
| Q4 25 | $30.9M | $-100.8M | ||
| Q3 25 | $30.1M | $-92.7M | ||
| Q2 25 | $9.2M | $-110.7M | ||
| Q1 25 | $4.9M | $-167.8M | ||
| Q4 24 | $19.1M | $-79.5M | ||
| Q3 24 | $14.5M | $-68.6M | ||
| Q2 24 | $23.6M | $-79.0M | ||
| Q1 24 | $6.7M | $-193.9M |
| Q4 25 | 12.5% | -48.6% | ||
| Q3 25 | 12.5% | -58.0% | ||
| Q2 25 | 3.8% | -66.5% | ||
| Q1 25 | 2.2% | -120.5% | ||
| Q4 24 | 8.4% | -48.3% | ||
| Q3 24 | 6.4% | -49.2% | ||
| Q2 24 | 10.7% | -53.7% | ||
| Q1 24 | 3.3% | -178.2% |
| Q4 25 | 2.4% | 0.5% | ||
| Q3 25 | 2.5% | 0.8% | ||
| Q2 25 | 3.3% | 1.5% | ||
| Q1 25 | 2.3% | 1.0% | ||
| Q4 24 | 2.0% | 0.1% | ||
| Q3 24 | 2.3% | 1.2% | ||
| Q2 24 | 2.3% | 1.4% | ||
| Q1 24 | 3.2% | 3.0% |
| Q4 25 | 4.12× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 3.29× | — | ||
| Q3 24 | 1.87× | — | ||
| Q2 24 | 28.87× | — | ||
| Q1 24 | 2.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRTH
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
